Early diagnosis through thorough skin examination and multidisciplinary care at specialized cancer centers are essential for optimizing outcomes in cutaneous angiosarcoma.
Urges heightened vigilance for cutaneous angiosarcoma; leaves open optimal protocols pending prospective validation.
Cutaneous angiosarcoma (CAS) is a rare aggressive malignancy that most commonly manifests in White men older than 60 years and often appears as an enlarging ecchymosis on the head, neck, or scalp. Surgery with negative margins is the first-line treatment. The role of Mohs micrographic surgery (MMS) is uncertain but can be used in smaller, well-circumscribed lesions on the head and neck. The greatest impact that dermatologists can have in the management of CAS is through a thorough total-body skin examination and heightened awareness resulting in a shortened time to diagnosis. Until quality evidence allows for the creation of consensus guidelines, multidisciplinary care at a cancer center that specializes in rare difficult-to-treat tumors is essential in optimizing patient outcomes.
No takes yet. Share an insight, caveat, or question.
Elizabeth A. Richards (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: